South Florida COVID Testing Verdict: Why $15 Million Billed and $500,000 Paid Is a Sentencing Fight

A federal jury in the Southern District of Florida convicted a laboratory vice president and marketer on every count after a trial over drive-through COVID-19 testing at country clubs in the West Palm Beach area. Staff drew extra blood from seniors, and Medicare was billed for tests that no treating physician ordered. If you run a lab, a mobile testing business, or a marketing company that sends staff into senior communities, this verdict shows how prosecutors build a Medicare fraud case and why the dollar figure at sentencing becomes the fight.

Nearly 2,000 older patients came to country club testing events for nasal swabs and antibody tests. According to the Justice Department, staff drew additional blood for tests no physician ordered.

Key Takeaways

• A South Florida jury convicted a lab vice president of conspiracy and six counts of health care fraud, 18 U.S.C. §§ 1349 and 1347.
• Medicare was billed more than $15 million and paid more than $500,000, so the loss figure will drive the Southern District of Florida sentencing range.
• Each count carries up to 10 years under 18 U.S.C. § 1347, and the government says the add-on blood tests had no physician order.
• The Supreme Court hears Beaird v. United States on October 13, and it could limit how courts use Guidelines commentary to presume intended loss.
• Contact from HHS-OIG or the FBI is the stage where federal investigation defense can still shape charging decisions in South Florida healthcare fraud cases.

What Happened

On October 7, 2026, the Justice Department announced the conviction. The jury found the defendant guilty of one count of conspiracy to commit health care fraud and six counts of health care fraud, offenses that fall under 18 U.S.C. § 1349 and 18 U.S.C. § 1347. The maximum is 10 years on each count. Sentencing is expected in January 2027.

The government's evidence described a familiar format. The defendant promoted drive-through testing events at nine country clubs over about four months. Nearly 2,000 older patients came for nasal swabs and antibody tests. According to the Department, staff drew additional blood for unneeded tests, including hormone and heavy metal panels, without a physician's order. Medicare was then billed for those tests as medically necessary and ordered by a treating physician. The Department also says a doctor's name appeared on the claims without that doctor's authorization.

What the Government Is Building

The trial evidence the Department lists is a map of what a prosecutor wants from your files. The jury heard patient complaints that were sent to the defendant. It heard a complaint from one of the named doctors about the billing. It heard questions from country club managers about the extra blood draws. Together it proves notice, which is how a billing problem becomes willfulness.

Patient complaints, a doctor's billing complaint, and club managers' questions about the extra blood draws. Each one is notice, and notice is how a billing problem becomes willfulness.

A healthcare fraud investigation lawyer sees the same pattern in many South Florida cases. Claims data draws the first look, complaints supply the story, and agents then interview staff while a grand jury subpoena arrives. Marketers and lab executives often land in the group that ran the scheme because they control the volume.

Exposure and Charges

Health care fraud under 18 U.S.C. § 1347 requires proof that the defendant knowingly and willfully executed, or tried to execute, a scheme to defraud a health care benefit program or to obtain its money by false representations. Medicare is a health care benefit program under 18 U.S.C. § 24(b). Medicare pays for a service only when it is reasonable and necessary under 42 U.S.C. § 1395y(a)(1)(A), so a claim that labels an unordered test as medically necessary is the kind of statement the government treats as false. Conspiracy under § 1349 carries the same maximum as the object offense.

Prosecutors often add related counts. False statements relating to health care matters fall under 18 U.S.C. § 1035. Using a physician's identity without authority can support aggravated identity theft under 18 U.S.C. § 1028A, which adds a mandatory consecutive two years. Payments to a marketer per test or per patient can raise the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b. The Department does not say those counts were charged here, but a Medicare fraud lawyer should expect them in similar cases.

The FBI and HHS-OIG investigated this case. Using a physician's identity without authority can add aggravated identity theft and a mandatory consecutive two years.

The Sentencing Fight Turns on Loss

The sentencing fight turns on loss. Under Section 2B1.1 of the Guidelines, loss is the greater of actual or intended loss, and Application Note 3(F)(viii) makes the total billed to a government health care program prima facie evidence of intended loss. Under the table in force through October 31, 2026, loss above $550,000 adds 14 levels and loss above $9.5 million adds 20. By my count, moving from the paid figure to the billed figure is a six-level swing before any other adjustment.

Beaird, Dupree, and the November 1 Loss Table

Two developments matter. The Sentencing Commission adjusted the loss table for inflation effective November 1, 2026, and a sentencing set after that date uses the adjusted table. The Supreme Court also hears Beaird v. United States on October 13, a case about whether courts still defer to Guidelines commentary. The text of Section 2B1.1 never mentions intended loss. That concept lives in commentary, and in United States v. Dupree, 57 F.4th 1269 (11th Cir. 2023) (en banc), the Eleventh Circuit held that commentary cannot add to the text of a guideline. Preserve that loss amount dispute before the probation officer finalizes the PSR.

Intended loss lives in the Guidelines commentary, not the text of Section 2B1.1. In the Eleventh Circuit, Dupree holds that commentary cannot add to the text of a guideline.

Critical Mistakes People Make Early

The first mistake is talking to agents without counsel. A false or incomplete answer to an FBI agent can become its own charge under 18 U.S.C. § 1001. The second is ignoring complaints, which become notice evidence. The third is cleaning up records after the fact. Backdating an order or creating a signature after a subpoena arrives invites an obstruction count under 18 U.S.C. § 1519, and obstruction is easier to prove than fraud.

The fourth mistake is assuming the signing physician carries the risk. Prosecutors charge lab executives and marketers because they decide volume, scripts, and staffing. The fifth is waiting for an indictment before hiring a federal criminal defense attorney. By then the government has chosen its theory.

Strategic Defense Approach

Early intervention lets counsel run a privileged review of the claims, orders, and communications before the government frames them. It identifies who ordered each test and who authenticated each physician signature, which is where cases like this are won or lost. A federal target letter attorney or white collar defense attorney can also learn whether a client is a witness, a subject, or a target, and can present a pre-charge submission before the charging decision hardens.

A proffer session attorney protects the client's statements and limits what the government can use. Pre-charge negotiation with the AUSA is realistic for a mid-level participant who documented concerns, and much harder for the person who controlled the billing. If charges proceed, the defense shifts to the loss amount dispute, PSR objections, and a 3553(a) variance argument that treats paid dollars, not billed dollars, as the measure of harm.

Why Timing Matters

Charging decisions are fluid early in an investigation, and the window closes quickly. Most federal health care fraud counts carry the general five-year limitations period under 18 U.S.C. § 3282, and a conspiracy runs from its last act, so pandemic-period testing is not automatically out of reach. The Beaird argument on October 13 and the loss table change on November 1 both bear on how a billed-versus-paid case is valued. Anyone under federal investigation in Palm Beach, Broward, or Miami-Dade should assume the government is already comparing billed totals to paid totals.

Common Questions

Facing a Medicare Fraud Investigation in South Florida?

If you have received a grand jury subpoena, an HHS-OIG records request, or a letter from the U.S. Attorney's Office, or agents have contacted your staff, speak with counsel before you respond. AMC Defense Law handles federal investigations and prosecutions in the Southern District of Florida and nationwide, and every consultation is confidential.

A privileged review of claims, orders, and physician signatures lets AMC Defense Law contest the loss figure before the PSR is final and shape the charging decision before it hardens.

If you or your loved ones have been arrested or are under federal investigation, call Aaron M. Cohen for a confidential consultation, 24 hours a day to get help.

This article is for general informational purposes only and is not legal advice. Reading it does not create an attorney-client relationship. Every case turns on its own facts, and past results do not guarantee a similar outcome. Attorney advertising.

About the author: Aaron M. Cohen is the founder and principal attorney of AMC Defense Law, a criminal defense firm in Boca Raton, Florida, with more than 30 years of experience in state and federal courts. He is admitted to practice in Florida, New York, New Jersey, and the District of Columbia, and before the United States District Courts for the Southern and Middle Districts of Florida, the Southern, Eastern, and Western Districts of New York, the District of New Jersey, and the Northern District of Texas. He appears pro hac vice in other federal districts nationwide. The firm represents clients in federal investigations and prosecutions involving healthcare fraud, Anti-Kickback Statute matters, DME and telemedicine fraud, peptide and compounded-drug enforcement, controlled-substance and drug conspiracy cases, financial crimes, and complex federal litigation, in Florida and nationwide.